![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Grössmann, N. and Wolf, S. (2017): Horizon Scanning in Oncology 31st Prioritisation – 2nd quarter 2017 . HSO: 31st Prioritisation.
Preview |
PDF
- Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
141kB |
Abstract
For the 31st prioritisation (May 2017), 10 drugs were filtered out of 302 identified and were sent to prioritisation. Of these, 4 drugs were ranked as 'highly relevant' by the expert panel, 5 as 'relevant' and 1 as 'not relevant'. For 'highly relevant' drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.
| Item Type: | DSD: Horizon Scanning in Oncology |
|---|---|
| Subjects: | WB Practice of medicine > WB 300-962 Therapeutics QZ Pathology > QZ 200-380 Neoplasms.Cysts QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology |
| Language: | English |
| Series Name: | HSO: 31st Prioritisation |
| Deposited on: | 12 May 2017 12:03 |
| Last Modified: | 10 Jul 2025 11:26 |
Repository Staff Only: item control page